BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 24613933)

  • 21. Chapter 33: the history of movement disorders.
    Lanska DJ
    Handb Clin Neurol; 2010; 95():501-46. PubMed ID: 19892136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early-onset Dopamine Transporter Deficiency Syndrome: Long-term Follow-up.
    Baga M; Spagnoli C; Soliani L; Salerno GG; Rizzi S; Frattini D; Pisani F; Fusco C
    Can J Neurol Sci; 2021 Mar; 48(2):285-286. PubMed ID: 32646530
    [No Abstract]   [Full Text] [Related]  

  • 23. Phenotypic spectrum of patients with PLA2G6 mutation and PARK14-linked parkinsonism.
    Yoshino H; Tomiyama H; Tachibana N; Ogaki K; Li Y; Funayama M; Hashimoto T; Takashima S; Hattori N
    Neurology; 2010 Oct; 75(15):1356-61. PubMed ID: 20938027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of a Targeted Gene Panel for Identification of Genes Associated With Movement Disorders.
    Montaut S; Tranchant C; Drouot N; Rudolf G; Guissart C; Tarabeux J; Stemmelen T; Velt A; Fourrage C; Nitschké P; Gerard B; Mandel JL; Koenig M; Chelly J; Anheim M;
    JAMA Neurol; 2018 Oct; 75(10):1234-1245. PubMed ID: 29913018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Homozygous in-frame variant of SCL6A3 causes dopamine transporter deficiency syndrome in a consanguineous family.
    Heidari E; Razmara E; Hosseinpour S; Tavasoli AR; Garshasbi M
    Ann Hum Genet; 2020 Jul; 84(4):315-323. PubMed ID: 32077500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brain dopamine-serotonin vesicular transport disease and its treatment.
    Rilstone JJ; Alkhater RA; Minassian BA
    N Engl J Med; 2013 Feb; 368(6):543-50. PubMed ID: 23363473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebrospinal fluid synaptic proteins as useful biomarkers in tyrosine hydroxylase deficiency.
    Ortez C; Duarte ST; Ormazábal A; Serrano M; Pérez A; Pons R; Pineda M; Yapici Z; Fernández-Álvarez E; Domingo-Jiménez R; De Castro P; Artuch R; García-Cazorla A
    Mol Genet Metab; 2015 Jan; 114(1):34-40. PubMed ID: 25468651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Genetic Landscape of Complex Childhood-Onset Hyperkinetic Movement Disorders.
    Pérez-Dueñas B; Gorman K; Marcé-Grau A; Ortigoza-Escobar JD; Macaya A; Danti FR; Barwick K; Papandreou A; Ng J; Meyer E; Mohammad SS; Smith M; Muntoni F; Munot P; Uusimaa J; Vieira P; Sheridan E; Guerrini R; Cobben J; Yilmaz S; De Grandis E; Dale RC; Pons R; Peall KJ; Leuzzi V; Kurian MA
    Mov Disord; 2022 Nov; 37(11):2197-2209. PubMed ID: 36054588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-Activity Relationships of Dopamine Transporter Pharmacological Chaperones.
    Sutton C; Williams EQ; Homsi H; Beerepoot P; Nazari R; Han D; Ramsey AJ; Mash DC; Olson DE; Blough B; Salahpour A
    Front Cell Neurosci; 2022; 16():832536. PubMed ID: 35614973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical features of childhood-onset paroxysmal kinesigenic dyskinesia with PRRT2 gene mutations.
    Silveira-Moriyama L; Gardiner AR; Meyer E; King MD; Smith M; Rakshi K; Parker A; Mallick AA; Brown R; Vassallo G; Jardine PE; Guerreiro MM; Lees AJ; Houlden H; Kurian MA
    Dev Med Child Neurol; 2013 Apr; 55(4):327-34. PubMed ID: 23363396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Older-onset levodopa-responsive parkinsonism with normal DAT-SPECT and pterin hypometabolism.
    Togo K; Ishihara T; Yamamoto K; Sawada H
    BMJ Case Rep; 2021 May; 14(5):. PubMed ID: 33962918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A case report of infantile parkinsonism-dystonia-2 caused by homozygous mutation in the
    Zhai H; Zheng Y; He Y; Zhang Y; Guo Z; Cui W; Sun L
    Int J Neurosci; 2023 May; 133(5):574-577. PubMed ID: 34078222
    [No Abstract]   [Full Text] [Related]  

  • 33. Parkinsonism in children: Clinical classification and etiological spectrum.
    Leuzzi V; Nardecchia F; Pons R; Galosi S
    Parkinsonism Relat Disord; 2021 Jan; 82():150-157. PubMed ID: 33109474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuropsychiatric disease-associated genetic variants of the dopamine transporter display heterogeneous molecular phenotypes.
    Herborg F; Andreassen TF; Berlin F; Loland CJ; Gether U
    J Biol Chem; 2018 May; 293(19):7250-7262. PubMed ID: 29559554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genotype-phenotype correlation in seven motor neuron disease families with novel ALS2 mutations.
    Sprute R; Jergas H; Ölmez A; Alawbathani S; Karasoy H; Dafsari HS; Becker K; Daimagüler HS; Nürnberg P; Muntoni F; Topaloglu H; Uyanik G; Cirak S
    Am J Med Genet A; 2021 Feb; 185(2):344-354. PubMed ID: 33155358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dystonia and Parkinsonism in COA7-related disorders: expanding the phenotypic spectrum.
    Higuchi Y; Ando M; Kojima F; Yuan J; Hashiguchi A; Yoshimura A; Hiramatsu Y; Nozuma S; Fukumura S; Yahikozawa H; Abe E; Toyoshima I; Sugawara M; Okamoto Y; Matsuura E; Takashima H
    J Neurol; 2024 Jan; 271(1):419-430. PubMed ID: 37750949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parkinsonism in PGK1 deficiency implicates the glycolytic pathway in nigrostriatal dysfunction.
    Morales-Briceño H; Ha AD; London K; Farlow D; Chang FCF; Fung VSC
    Parkinsonism Relat Disord; 2019 Jul; 64():319-323. PubMed ID: 30975619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ADCY5-related movement disorders: Frequency, disease course and phenotypic variability in a cohort of paediatric patients.
    Carecchio M; Mencacci NE; Iodice A; Pons R; Panteghini C; Zorzi G; Zibordi F; Bonakis A; Dinopoulos A; Jankovic J; Stefanis L; Bhatia KP; Monti V; R'Bibo L; Veneziano L; Garavaglia B; Fusco C; Wood N; Stamelou M; Nardocci N
    Parkinsonism Relat Disord; 2017 Aug; 41():37-43. PubMed ID: 28511835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine transporter imaging (123)I-FP-CIT (DaTSCAN) SPET in differential diagnosis of dopa-responsive dystonia and young-onset Parkinson's disease.
    Brajkovic LD; Svetel MV; Kostic VS; Sobic-Saranovic DP; Pavlovic SV; Artiko VM; Obradovic VB
    Hell J Nucl Med; 2012; 15(2):134-8. PubMed ID: 22833860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Significance of the parkin and PINK1 gene in Jordanian families with incidences of young-onset and juvenile parkinsonism.
    Myhre R; Steinkjer S; Stormyr A; Nilsen GL; Abu Zayyad H; Horany K; Nusier MK; Klungland H
    BMC Neurol; 2008 Dec; 8():47. PubMed ID: 19087301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.